Cite
HARVARD Citation
Nakaya, A. et al. (n.d.). Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?. Leukemia research. pp. 46-49. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nakaya, A. et al. (n.d.). Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?. Leukemia research. pp. 46-49. [Online].